-
Mashup Score: 4AI and the FDA - 4 hour(s) ago
A recent Special Communication published in JAMA points out that the FDA has already approved nearly 1000 devices using AI. Author Robert M. Califf, MD, commissioner of the US Food and Drug Administration, joins JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss AI regulation.
Source: edhub.ama-assn.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib - 13 hour(s) ago
Interview with Hagop Kantarjian, MD, author of Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial. Hosted by Vivek Subbiah, MD.
Source: edhub.ama-assn.orgCategories: General Medicine News, Oncologists1Tweet-
Listen to an interview with @DrHKantarjian author of "Olverembatinib After Failure of TKIs, Including Ponatinib or Asciminib: A Phase 1b/2 Randomized Clinical Trial in CML" hosted by @VivekSubbiah. @AMAEdHub https://t.co/yDzkBKJ701 https://t.co/uvuRf7YY8a
-
-
Mashup Score: 7
Mpox is an evolving global health threat, and clinicians should be aware of characteristic signs and symptoms to ensure timely diagnosis and appropriate management. Author Jason Zucker, MD, MS, of Columbia University Irving Medical Center speaks with JAMA Deputy Editor Preeti Malani, MD, MSJ, about the transmission, diagnosis, management, and prevention of mpox.
Source: edhub.ama-assn.orgCategories: General Medicine News, General HCPsTweet-
Author Jason Zucker of @ColumbiaMed speaks with JAMA Deputy Editor @PreetiNMalani about the transmission, diagnosis, management, and prevention of mpox. Listen on @AMAEdHub. https://t.co/t3tqsMue7d https://t.co/tvSd97sFgL
-
-
Mashup Score: 6The Value of Feeling Valued Playbook - 3 day(s) ago
This playbook offers strategies to help physicians and other leaders build a culture of wellness and work-life integration for clinicians. This culture includes flexible schedules, protected paid time off, career development, and individual resilience and self-care.
Source: edhub.ama-assn.orgCategories: General Medicine News, General HCPsTweet-
Foster a culture of well-being for your physicians with the new open-access #AMAStepsForward "Value of Feeling Valued Playbook." Combat #burnout with actionable tips on boosting resiliency, professional development and more – dive in on @AMAEdHub today. https://t.co/eVJAFZ5d9p
-
-
Mashup Score: 4Antidiabetic Medication and Asthma Attacks - 4 day(s) ago
Interview with Chloe I. Bloom, BSc, MSc, PhD, author of Antidiabetic Medication and Asthma Attacks, and Katherine N. Cahill, MD, author of Borrowing From the Type 2 Diabetes Armamentarium for Asthma. Hosted by Eve Rittenberg, MD.
Source: edhub.ama-assn.orgCategories: General Medicine News, General HCPsTweet-
Listen to an interview with JAMA Internal Medicine authors @chloebloom and Katherine Cahill hosted by Eve Rittenberg. Episode on @AMAEdHub. https://t.co/2twRNh613C https://t.co/kj2CefxAWa
-
-
Mashup Score: 8
Elevated lipoprotein(a) levels increase the risk of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. Cleveland Clinic’s Steven E. Nissen, MD, speaks with JAMA Executive Editor Gregory Curfman, MD, about how zerlasiran produced more than 80% reductions in time-averaged lipoprotein(a) concentration.
Source: edhub.ama-assn.orgCategories: General Medicine News, General HCPsTweet-
Steven Nissen from @ClevelandClinic speaks with JAMA Executive Editor Gregory Curfman about how zerlasiran produced more than 80% reductions in time-averaged lipoprotein(a) concentration. https://t.co/rjr5uwjR46 #AHA24 https://t.co/dd8fxip0rx
-
-
Mashup Score: 2USPSTF Recommendation: Screening for Breast Cancer - 5 day(s) ago
Interview with Wanda K. Nicholson, MD, MPH, MBA, USPSTF Chair and coauthor of Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS.
Source: edhub.ama-assn.orgCategories: General Medicine News, General Journals & SocietTweet-
The USPSTF now recommends biennial screening mammography for women aged 40 to 74 years. @wnicholsonobgyn, USPSTF Chair, discusses the rationale behind the updated guidelines. 🎧 Listen to the podcast: https://t.co/ohHHMeSlzh ➡️ Watch the video: https://t.co/1wB1O8Qzwc
-
-
Mashup Score: 1
Editor’s Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from November 9-15, 2024.
Source: edhub.ama-assn.orgCategories: General Medicine News, General HCPsTweet-
JAMA Deputy Editors Linda Brubaker and @PreetiNMalani give a summary of articles published from November 9-15. Hosted on @AMAEdHub. https://t.co/xxZ6EpnD9t https://t.co/j0aPbnaG96
-
-
Mashup Score: 7The Ethics of AI as Clinical Decision Maker - 6 day(s) ago
A recent JAMA Cardiology essay argues that medicine is not just a technical endeavor, it’s also a moral endeavor, and a robot does not have moral agency. Coauthor Sarah C. Hull, MD, MBE, of Yale School of Medicine, joins JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, to discuss the use of AI in managing decision-making in cardiac care.
Source: edhub.ama-assn.orgCategories: General Medicine News, General HCPsTweet-
Listen to a discussion of AI and Clinical Practice with @hull_md. Hosted on @AMAEdHub. https://t.co/E3GTbJ4IJH https://t.co/4VUF7rrdYr
-
-
Mashup Score: 12Managing Type 2 Diabetes - 8 day(s) ago
Identifying patients with prediabetes and intervening early to prevent progression to diabetes is paramount. The good news is that simple interventions can make a big difference and save time.
Source: edhub.ama-assn.orgCategories: General Medicine News, General HCPsTweet-
In recognition of #WorldDiabetesDay, we're sharing an essential toolkit for helping patients manage type 2 diabetes. Learn how to pinpoint opportunities to improve the health of patients with prediabetes and diabetes while saving care team time. https://t.co/Q9mWO9KBEV
-
Author Robert Califf, commissioner of @US_FDA, joins JAMA+ AI Editor in Chief Roy Perlis to discuss AI regulation. https://t.co/tpzh1Y3imN https://t.co/FGc3ktCygW